Vicore Pharma Holding
9.81 SEK
-2.68 %
Less than 1K followers
VICO
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-2.68 %
-5.67 %
-13.19 %
-1.90 %
-11.46 %
+35.12 %
-29.10 %
-63.34 %
+94.26 %
Vicore Pharma operates in the pharmaceutical industry and focuses on the development of innovative treatments for pulmonary and cardiovascular diseases. The company researches new therapies that can improve patient outcomes and quality of life. The business is global with a primary presence in Europe and North America. Vicore Pharma was founded in 2000 and is headquartered in Gothenburg, Sweden.
Read moreMarket cap
2.76B SEK
Turnover
3.24M SEK
Revenue
3.82M
EBIT %
-11,851.87 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
6/5
2026
General meeting '26
6/5
2026
Interim report Q1'26
21/8
2026
Interim report Q2'26
All
Webcasts
Press releases
ShowingAll content types
Vicore Pharma to Present at Upcoming Investor Conferences
Vicore Pharma stärker ledningsgruppen inför kommande viktiga milstolpar
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools